what's the word on Eohilia (TAK-721)?

[anonymous]

Sorry to hijack the employee message boards. but i'm desperate for word on Eohilia's approval -- or lack there of, the 6-month priority review window ended in Apr 2021. My daughter uses the budesonide slurry and we'd love to stop compounding this crap w/ a bunch of honey and instead just take Eohilia. I fear that Takeda has either bungled this approval or given up on the drug altogether. if you aren't comfortable posting here, you can msg me on instagram jbt416. all anonymous. i just want to know if i should stop hoping for this drug and move on. thank you!

 

[anonymous]

Sorry to hijack the employee message boards. but i'm desperate for word on Eohilia's approval -- or lack there of, the 6-month priority review window ended in Apr 2021. My daughter uses the budesonide slurry and we'd love to stop compounding this crap w/ a bunch of honey and instead just take Eohilia. I fear that Takeda has either bungled this approval or given up on the drug altogether. if you aren't comfortable posting here, you can msg me on instagram jbt416. all anonymous. i just want to know if i should stop hoping for this drug and move on. thank you!

Dead in the water

 

[anonymous]

Sorry to hijack the employee message boards. but i'm desperate for word on Eohilia's approval -- or lack there of, the 6-month priority review window ended in Apr 2021. My daughter uses the budesonide slurry and we'd love to stop compounding this crap w/ a bunch of honey and instead just take Eohilia. I fear that Takeda has either bungled this approval or given up on the drug altogether. if you aren't comfortable posting here, you can msg me on instagram jbt416. all anonymous. i just want to know if i should stop hoping for this drug and move on. thank you!

Go troll someplace else.

 

[anonymous]

Don’t hold your breath with Takeda. Dupixent will likely get approved before.

 

[anonymous]

Don’t hold your breath with Takeda. Dupixent will likely get approved before.

And with better coverage since TAK doesn’t play well with Payers. Unless they pull the plays from the Entyvio book

 

[anonymous]

dead in the water because TAK isnt interested in manufacturing/selling the drug? or because FDA killed it? did FDA issue a CRL?

 

[anonymous]

CRL indicates the FDA has completed its review of the TAK-721 NDA and determined that it cannot be approved in its present form

 

[anonymous]

Dead